Financial Snapshot

Revenue
$3.261B
TTM
Gross Margin
21.13%
TTM
Net Earnings
$86.16M
TTM
Current Assets
Q4 2024
Current Liabilities
Q4 2024
Current Ratio
133.3%
Q4 2024
Total Assets
Q4 2024
Total Liabilities
Q4 2024
Book Value
$1.578B
Q4 2024
Cash
Q4 2024
P/E
12.52
Apr 15, 2025 EST
Free Cash Flow
$235.8M
TTM

Revenues

Revenues

Revenue YoY Change

Revenues

Concept 2024 2023 2022 2021 2020 2019 2018 2017
Revenue $3.261B $3.200B $2.971B $2.455B $1.056B $529.6M $0.00 $0.00
YoY Change 1.9% 7.73% 21.02% 132.35% 99.45%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept 2024 2023 2022 2021 2020 2019 2018 2017
Revenue $3.261B $3.200B $2.971B $2.455B $1.056B $529.6M $0.00 $0.00
Cost Of Revenue $2.580B $2.721B $2.553B $2.009B $898.6M $440.7M
Gross Profit $681.1M $479.6M $417.4M $445.6M $157.8M $88.94M
Gross Profit Margin 20.89% 14.99% 14.05% 18.15% 14.94% 16.79%

Selling, General & Admin Expense

Research & Development

No data

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

No data

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operating Profits/Loss YoY Change

Operating Earnings to Gross Profit Ratio

Operating Profit Margin

Operational Expenses

Concept 2024 2023 2022 2021 2020 2019 2018 2017
Selling, General & Admin $424.9M $190.1M $245.7M $234.6M $111.4M $68.90M $1.200M $0.00
YoY Change 123.53% -22.63% 4.74% 110.58% 61.68% 5641.67%
% of Gross Profit 62.39% 39.64% 58.86% 52.64% 70.6% 77.47%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $365.3M $382.8M $351.2M $258.1M $82.45M $62.57M
YoY Change -4.56% 9.0% 36.09% 213.0% 31.77%
% of Gross Profit 53.64% 79.82% 84.13% 57.91% 52.25% 70.35%
Operating Expenses $470.0M $247.2M $310.6M $297.7M $122.8M $72.00M $1.200M $0.00
YoY Change 90.13% -20.42% 4.33% 142.42% 70.56% 5900.0%
Operating Profit $263.7M -$598.4M $190.4M $225.6M $71.35M $29.38M
YoY Change -144.07% -414.27% -15.6% 216.21% 142.86%
Operating Profit To Gross Profit 38.72% -124.78% 45.62% 50.63% 45.22% 33.03%
Operating Profit To Revenue 8.09% -18.7% 6.41% 9.19% 6.75% 5.55%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017
Interest Expense -$126.7M $130.3M $109.4M $95.20M $41.43M $39.30M $4.100M
YoY Change -197.21% 19.09% 14.94% 129.77% 5.41% 858.63%
% of Operating Profit -48.03% 57.46% 42.2% 58.07% 133.79%
Other Income/Expense, Net -$2.793M -$29.57M -$253.0K -$1.832M $3.444M $318.0K
YoY Change -90.55% 11586.17% -86.19% -153.19% 983.02%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017
Pretax Income $136.0M -$723.8M $97.90M $191.0M -$206.0M -$21.86M $2.900M $0.00
YoY Change -118.79% -839.29% -48.73% -192.68% 842.46% -853.86%
Income Tax $41.24M -$49.00M $24.77M $32.81M -$11.96M $739.0K $800.0K $0.00
% Of Pretax Income 30.32% 25.3% 17.18% 27.59%
Net Earnings $90.42M -$678.9M $69.32M $156.2M -$161.6M -$21.34M $2.100M $0.00
YoY Change -113.32% -1079.42% -55.62% -196.62% 657.38% -1116.24%
Net Earnings / Revenue 2.77% -21.21% 2.33% 6.36% -15.3% -4.03%
Basic Earnings Per Share $0.62 -$5.06 $0.47 $1.12 -$3.08 -$0.95
Diluted Earnings Per Share $0.61 -$5.31 $0.33 $0.67 -$3.08 -$0.95 $67.09K $0.00

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

No data

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept 2024 2023 2022 2021 2020 2019 2018 2017
Cash & Short-Term Investments $109.7M $77.13M $46.27M $149.6M $100.0M $76.90M $900.0K $100.0K
YoY Change 42.28% 66.69% -69.08% 49.63% 30.04% 8444.44% 800.0%
Cash & Equivalents $0.00
Short-Term Investments $14.00K $5.600M $54.00M
Other Short-Term Assets $98.18M $69.34M $52.14M $37.44M $33.40M $12.70M $200.0K
YoY Change 41.6% 32.99% 39.25% 12.1% 162.99% 6250.0%
Inventory $139.8M $113.6M $127.8M $123.1M $58.80M $13.20M
Prepaid Expenses
Receivables $408.0M $388.9M $359.1M $359.9M $171.1M $78.60M
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $755.8M $649.0M $585.3M $670.1M $363.3M $181.4M $1.100M $100.0K
YoY Change 16.45% 10.89% -12.65% 84.44% 100.28% 16390.91% 1000.0%
Property, Plant & Equipment $618.4M $637.5M $622.0M $546.3M $110.5M $63.60M
YoY Change -3.01% 2.5% 13.85% 394.42% 73.74%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $332.1M $367.0M $304.2M $319.3M $224.9M $34.80M $253.0M $200.0K
YoY Change -9.51% 20.64% -4.73% 41.97% 546.26% -86.25% 126400.0%
Total Long-Term Assets $3.731B $3.860B $4.634B $4.580B $1.450B $365.1M $253.0M $200.0K
YoY Change -3.33% -16.72% 1.18% 215.85% 297.21% 44.31% 126400.0%
Total Assets $4.487B $4.509B $5.220B $5.250B $1.814B $546.5M $254.1M $300.0K
YoY Change
Accounts Payable $354.5M $257.9M $266.7M $248.0M $191.0M $79.20M $0.00 $100.0K
YoY Change 37.49% -3.33% 7.55% 29.86% 141.16% -100.0%
Accrued Expenses $113.4M $163.4M $100.8M $95.89M $37.80M $16.30M $500.0K $100.0K
YoY Change -30.61% 62.18% 5.07% 153.68% 131.9% 3160.0% 400.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $200.0K
YoY Change -100.0%
Long-Term Debt Due $30.57M $62.49M $37.21M $35.45M $30.40M $21.50M
YoY Change -51.09% 67.93% 4.98% 16.6% 41.4%
Total Short-Term Liabilities $567.0M $537.0M $456.2M $499.8M $422.1M $154.1M $700.0K $300.0K
YoY Change 5.58% 17.71% -8.72% 18.41% 173.91% 21914.29% 133.33%
Long-Term Debt $1.990B $2.117B $2.157B $2.184B $777.4M $395.1M $0.00 $0.00
YoY Change -6.04% -1.85% -1.21% 180.9% 96.76%
Other Long-Term Liabilities $352.3M $387.6M $448.4M $500.3M $333.1M $63.20M $7.900M
YoY Change -9.11% -13.55% -10.37% 50.19% 427.06% 700.0%
Total Long-Term Liabilities $2.342B $2.505B $2.606B $2.684B $1.111B $458.3M $7.900M $0.00
YoY Change -6.51% -3.86% -2.92% 141.69% 142.31% 5701.27%
Total Liabilities $2.916B $3.050B $3.068B $3.189B $1.459B $585.4M $8.600M $300.0K
YoY Change -4.41% -0.59% -3.77% 118.61% 149.16% 6706.98% 2766.67%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

No data

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept 2024 2023 2022 2021 2020 2019 2018 2017
Basic Shares Outstanding 133.8M shares 134.2M shares 134.2M shares 126.3M 52.49M 22.56M
Diluted Shares Outstanding 135.5M shares 134.4M shares 139.0M shares 133.0M 52.49M 22.56M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Dividends

No data

Stock Price

Market Cap: $1.0789 Billion

About Adapthealth Corp

AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. The company is headquartered in Plymouth Meeting, Pennsylvania and currently employs 10,500 full-time employees. The company went IPO on 2018-02-21. The firm is primarily focused on providing sleep therapy equipment, supplies and related services, including CPAP and bi PAP services to individuals suffering from obstructive sleep apnea (OSA); medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors (CGM) and insulin pumps; home medical equipment to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The firm services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company serves patients annually in all 50 states through its network of approximately 680 locations in 47 states.

Industry: Services-Home Health Care Services Peers: Cencora Inc Cardinal Health Inc COVETRUS, INC. Henry Schein Inc Mckesson Corp Patterson Companies Inc Owens & Minor Inc PetIQ, Inc.